- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06617806
Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults (APN-FIT)
Advanced Practice Nurses for Fall Incidence PrevenTion in Robust Very Old Adults: Protocol for the APN-FIT Hybrid Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction and objectives
The 2020s witnessed the emergence of Advanced Practice Nurses (APN) as a novel paramedical profession in France, bolstering the primary care workforce and service landscape. These nurses are expected to reinforce various dimensions of primary care, including therapeutic education, prevention, screening, and clinical and therapeutic follow-up of patients. There is a need regarding the evaluation of APN led intervention in the prevention of falls in non-frail elderly.
APN-FIT is a pragmatic, hybrid type 1, multicenter, randomized open-label superiority trial addressing this question. The study population will include primary care patients aged over 80 years old, classified as vigorous (according to Clinical Frailty Scale) and able to follow a tailored intervention program. The study will be conducted in seven local primary-care centers in the Pays de la Loire region of France.
Preselection will be done by GPs and APNs, recruitment will be done by APNs in their local caregiving center. APNs will perform a complete comprehensive geriatric assessment (CGA) for each participant at enrolment, followed by a detailed analysis of the resulting data and the emission of a panel of recommendation. A 1:1 randomization of participants will be conducted using a random block size ranging from 4 to 6, stratified by APN.
All participants will benefit from a CGA at inclusion and M12. A home-based physical activity program, over a period of 7 weeks, with twice-weekly sessions (45 min each), will also be proposed to all participants. In the intervention group, each APN will schedule follow-ups at 1, 3, 6, 9, and 12 months post-inclusion. Each participant will be contacted every two months (i.e 2,4,6,8,10 onths) by the research assistant or nurse for data collection on falls and secondary outcome criteria in a blinded approach. All participants will be assessed for a new CGA at M12 by a research nurse.
Quantitative main analysis
The primary outcome is the number of falls recorded at 12 months.
Secondary outcomes include:
- Number of falls and severe falls as defined by the World Fall Guidelines at each time point
- Level of independence, evaluated by Katz' index and Lawton's instrumental activities of daily living
- Level of healthcare utilization
- Level of emergency care service utilization
- Frailty measured with the Clinical Frailty Scale and ICOPE monitor score
- Cognitive performance
- Mental health status
- Nutritional status
- Quality of life evaluated by EQ-5D-5L
A cost-utility analysis (CUA) will be conducted, from a collective perspective and one-year time horizon.
Ancillary study of implementation
An ancillary study will be conducted to facilitate a deeper understanding of the efficacy elements observed in the main study. Its purpose is to determine optimal implementation conditions for practical deployment in the field. The data collection for this ancillary study is primarily opportunistic, coinciding with the data collection necessary to address the main study's primary objective. The indicators described by Proctor and colleagues will be used for the evaluation : acceptability, relevance, adoption, efficiency, feasibility, fidelity, scope and sustainability.
The implementation will undergo evaluation at patient level and healthcare provider level. Individual and group interviews will be conducted. Discourse saturation will be sought. The survey of professionals will occur during initial observations and focus groups. The data analysis will draw from the sociology of professions. A sequential thematic analysis of discourse and a visual examination of non-verbal communication elements and social interactions will be used to capture factors that facilitate or limit program implementation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laure DE DECKER, MD - Pr
- Phone Number: +332 02.40.08.79.20
- Email: laure.dedecker@chu-nantes.fr
Study Contact Backup
- Name: Cédric RAT, MD - Pr
- Email: cedric.rat@univ-nantes.fr
Study Locations
-
-
Loire-Atlantique
-
Nantes, Loire-Atlantique, France, 44
- Recruiting
- Chu Nantes
-
Contact:
- Laure De DECKER, MD PhD
- Phone Number: +33 0240083333
- Email: laure.dedecker@chu-nantes.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Aged 80 or over;
- Vigorous according to the " Clinical Frailty Scale " (scores 1, 2, 3) ;
- Having a referring primary care physician working in pairs with the local Advanced Practice Nurse;
- affiliated to a Health Care Plan
- Informed and having signed consent to participate in the research.
Exclusion criteria:
- Under guardianship or trusteeship;
- Unable to travel to the primary care office or unable to follow the adapted physical activity program;
- Poor understanding of French.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Advanced Practice Nurse Follow-up
The patient is followed-up by his Advanced Practice Nurse and General Practitionner The Advanced Practice Nurse (APN) will schedule follow-ups at 1, 3, 6, 9, and 12 months post-inclusion, leveraging their full range of skills and scope of practice. At each follow-up, the APN will ensure that the initial recommendations are being followed and will adjust them according to the patient's progress. The APN will work closely with all actors involved, including the adapted physical activity professional, attending physician, pharmacist, care assistant, and nurse. As for all participants, two CGAs will be performed at inclusion by APN and at M12 by the research nurse. An Adapted Physical Activity (APA) program will also be included. Participants will receive an APA falls prevention program consisting of 14 sessions, each lasting 45 minutes, conducted by a professional APA teacher in the comfort of their own home. |
At each follow-up (FU), the recommendations of an APN may include :
|
|
No Intervention: Usual Care
Short version: The patient is handled by his General Practitionner as usual after the first CGA Extended version: As for all participants, two CGAs will be performed at inclusion by APN and at M12 by the research nurse. An Adapted Physical Activity (APA) program will also be included. Participants will receive an APA falls prevention program consisting of 14 sessions, each lasting 45 minutes, conducted by a professional APA teacher in the comfort of their own home. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of falls in each group
Time Frame: 12 months after enrollment in the study
|
An unexpected event in which an individual comes to rest on the ground, floor, or lower level
|
12 months after enrollment in the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of falls and severe falls at each time point
Time Frame: 2-4-6-8-10 and 12 months after inclusion
|
Severe falls is defined by the World Fall Guidelines (2022) as "fall with injuries that are severe enough to require a consultation with a physician; result in the person lying on the ground without capacity to get up for at least one hour; prompt a visit to the emergency room (ER); associated with loss of consciousness"
|
2-4-6-8-10 and 12 months after inclusion
|
|
Level of independance
Time Frame: 12 months after inclusion
|
Activities of daily living (Katz index) and Lawton's instrumental activities of daily livng
|
12 months after inclusion
|
|
Level of healthcare utilization
Time Frame: 12 months after inclusion
|
Number of consultations, utilization of dental, ophthalmological, and ear-nose-throat care during the follow-up period
|
12 months after inclusion
|
|
Level of emergency care service utilization
Time Frame: 12 months after inclusion
|
Number of stays in an emergency hospitalization unit during the follow-up period.
|
12 months after inclusion
|
|
Cognitive performance and mental status
Time Frame: 12 months after inclusion
|
MMSE (mini mental state examination) and FAB (frontal assessment battery) score for cognition.
Mini-geriatric depression scale for mental health
|
12 months after inclusion
|
|
Quality of Life
Time Frame: 12 months after inclusion
|
Evaluated by EQ-5D-5L scale
|
12 months after inclusion
|
|
Frailty and physical performance
Time Frame: 12 months after inclusion
|
Frailty measured by the Clinical Frailty scale and Integrated Care for Older People (ICOPE) Monitor score Physical performance assessed with Timed Up and Go test and the Short Physical Performance Battery
|
12 months after inclusion
|
|
Number of participants with malnutrition
Time Frame: 12 months after inclusion
|
Body mass index, weight loss and Mini Nutritional Assessment
|
12 months after inclusion
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost utility analysis
Time Frame: 12 months after inclusion
|
Rate of Differential Cost - Utility
|
12 months after inclusion
|
|
Implementation outcomes of the intervention
Time Frame: 12 months after the end of the study
|
|
12 months after the end of the study
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Laure DE DECKER, MD - Pr, Nantes University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RC23_0018
- Mécénat AXA 2022 (Other Grant/Funding Number: AXA Life Insurance Company)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.